RxDoctor Payments Data

Shannon Shaffer

Family · Cleveland, OHNPI 1902267040

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 63.5% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $14,340, more than ten times the $487 reported in 2021. Among family clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,044in general payments, 2019–2025

Across 111 payments — averaging $198.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$14K
  • Abbott$2K
  • Medtronic$2K
  • Acadia Pharmaceuticals Inc$2K
  • MDD US Operations, LLC$1K
  • Amneal Pharmaceuticals LLC$825
  • plus $55 from 2 others
$280in research payments, 2019–2025

Across 1 payment — averaging $280.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$280

What the payments were for

  • Consulting fees$11,17851%
  • Speaking & faculty fees$1,0805%
  • Travel & lodging$7,06032%
  • Food & beverage$2,66412%
  • Education$620%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,044 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$37,906
Medicare patients
194
Services billed
674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuplazidPimavanserin Tartrate113$543,925
RytaryCarbidopa/Levodopa131$198,769
DuopaCarbidopa/Levodopa12$79,145
NourianzIstradefylline17$31,271
Carbidopa-LevodopaCarbidopa/Levodopa347$10,903
Rasagiline Mesylate59$9,487
Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone27$9,272
AmantadineAmantadine Hcl131$7,739
Carbidopa-Levodopa ErCarbidopa/Levodopa152$5,826
Entacapone19$2,545
Midodrine Hcl16$2,300
Rivastigmine15$1,971
Ropinirole ErRopinirole Hcl13$1,813
Primidone54$1,539
Pramipexole DihydrochloridePramipexole Di-Hcl58$1,458

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$1,673$543,925113 claims
Amneal Pharmaceuticals LLCRytary$825$198,769131 claims
AbbVieDuopa$14,000$79,14512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.

Other family in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →